Skip to content

A Novel Target and Biological Therapeutics for Conditions Involving Neovascularization and Fibrosis - Two Programs

1: DARETherapeutics program - novel biologics for treatment of nAMD and DME/DR related blindness. 2: treating fibrosis in liver, kidney, gut

Published: 25th June 2019
A Novel Target and Biological Therapeutics for Conditions Involving Neovascularization and Fibrosis - Two Programs
Header image provided by university
Patents
  • Intellectual property rights are held by University of Southern Denmark : US9,988,442 and EP14743707.3 and WO2019086580 and PCT/EP2022/059600
IP Status
  • Patent application submitted
  • Patented
Seeking
  • Seeking investment
  • Development partner
  • Commercial partner
  • Licensing